19
The University of Texas MD Anderson Cancer Center, based in U.S.A, is a pharmaceutical company.
One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 203246 and regulatory information .
proudly manufactured in the
approval since 2014-01-13
The University of Texas MD Anderson Cancer Center's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 20-150mCi/ML of FLUDEOXYGLUCOSE F-18.
18
The University of Texas MD Anderson Cancer Center, based in U.S.A, is a pharmaceutical company.
One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 203246 and regulatory information .
proudly manufactured in the
approval since 2014-01-13
The University of Texas MD Anderson Cancer Center's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 20-300mCi/ML of FLUDEOXYGLUCOSE F-18.